U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H10Br4O10S2
Molecular Weight 794.033
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFOBROMOPHTHALEIN

SMILES

OC1=CC=C(C=C1S(O)(=O)=O)C2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O

InChI

InChIKey=OHTXTCNTQJFRIG-UHFFFAOYSA-N
InChI=1S/C20H10Br4O10S2/c21-15-13-14(16(22)18(24)17(15)23)20(34-19(13)27,7-1-3-9(25)11(5-7)35(28,29)30)8-2-4-10(26)12(6-8)36(31,32)33/h1-6,25-26H,(H,28,29,30)(H,31,32,33)

HIDE SMILES / InChI

Molecular Formula C20H10Br4O10S2
Molecular Weight 794.033
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Sulfobromophthalein (BSP) is a dye with a high affinity for organic anion transporting polypeptides (OATPs) and has been used as a substrate for multidrug resistance associated protein 2 (Mrp2). BSP is transported into hepatocytes by OATPs and, after conjugation to glutathione, is excreted into bile by Mrp2.3 It was found to inhibit the aldo-keto reductase ARK1C20. Sulfobromophthalein (BSP) is used in diagnosis of hepatic disorders.It is also used for the quantitative determination of proteins.

Originator

Curator's Comment: Sulfobromophthalein sodium (BSP, Bromsulphalein) has been used extensively for testing hepatic function since its introduction by Rosenthal and White in 1925

Approval Year

PubMed

PubMed

TitleDatePubMed
Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2).
2003 Oct 17
Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver.
2008 Jan
Patents

Sample Use Guides

Rats: 350mg/day, i.v.
Route of Administration: Intravenous
In Vitro Use Guide
In competitive binding studies in vitro between Sulfobromophthalein (BSP) and a series of organic anions (sodium fluorescein, indocyanine green, bilirubin, sodium taurocholate, flavaspidic acid glucaminate, and iodipamide methylglucamine), the incubation mixture contained 500 ug of BSP and equimolar amounts of the aforementional organic anions. On the average, 160 +/- 2 ug BSP was bound per mg of membrane protein and 1.4 +/-0.1 ug BSP bound per unit of Co++-CMPase activity in 15 membrane isolates. BSP binding was maximal at 500 ug BSP/ml in the incubation mix with proportionately less binding observed at lower concentrations. BSP concentrations above 500 ug/ml reduced BSP binding and produced dissolution of cell membranes.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:43:53 UTC 2023
Edited
by admin
on Fri Dec 15 16:43:53 UTC 2023
Record UNII
0C2P5QKL36
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SULFOBROMOPHTHALEIN
Common Name English
SULFOBROMOPHTALEIN
Common Name English
SULFOBROMOPHTHALEIN FREE ACID
Common Name English
SULFOBROMPHTHALEIN
WHO-DD  
Common Name English
4,5,6,7-TETRABROMO-3',3''-DISULFOPHENOLPHTHALEIN
Common Name English
BENZENESULFONIC ACID, 3,3'-(4,5,6,7-TETRABROMO-3-OXO-1(3H)-ISOBENZOFURANYLIDENE)BIS(6-HYDROXY-
Common Name English
Sulfobromphthalein [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC V04CE02
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
WHO-VATC QV04CE02
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
NCI_THESAURUS C461
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C87724
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
FDA UNII
0C2P5QKL36
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
SMS_ID
100000077544
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
CHEBI
63836
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
DRUG BANK
DB13215
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
RXCUI
10212
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY RxNorm
ECHA (EC/EINECS)
206-047-5
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
DRUG CENTRAL
2531
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
MESH
D013448
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
EVMPD
SUB15430MIG
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID4075378
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
PUBCHEM
5345
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
CAS
297-83-6
Created by admin on Fri Dec 15 16:43:53 UTC 2023 , Edited by admin on Fri Dec 15 16:43:53 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY